Tissue factor promotor polymorphism −603 A/G is associated with myocardial infarction

Tissue factor (TF), the main initiator of the extrinsic coagulation cascade is expressed in atherosclerotic lesions and contributes to coronary thrombus formation in myocardial infarction (MI). Circulating TF reflects intravascular TF activation but also adds to prothrombotic activation. Because the...

Full description

Saved in:
Bibliographic Details
Published inAtherosclerosis Vol. 177; no. 1; pp. 189 - 191
Main Authors Ott, Ilka, Koch, Werner, von Beckerath, Nicolas, de Waha, Rene, Malawaniec, Anna, Mehilli, Julinda, Schömig, Albert, Kastrati, Adnan
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier Ireland Ltd 01.11.2004
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Tissue factor (TF), the main initiator of the extrinsic coagulation cascade is expressed in atherosclerotic lesions and contributes to coronary thrombus formation in myocardial infarction (MI). Circulating TF reflects intravascular TF activation but also adds to prothrombotic activation. Because the G allele of the TF promotor polymorphism −603 A/G is associated with monocytic mRNA expression we evaluated its association with myocardial infarction, based on a recessive deleterious effect assumption. Patients with MI (MI; n = 793) and age and sex matched control subjects without coronary artery disease (C; n = 340) undergoing coronary angiography were included. In patients with MI, the −603 G (MI: 76%, C: 70%) allele was prevalent compared to the control group ( P = 0.04). Multivariate analysis revealed an odds ratio of 1.44 (confidence interval 1.07–1.93). Carriage of the −603 G allele is associated with an increased risk for myocardial infarction. Because higher plasma TF concentrations are found in −603 G carriers enhanced TF expression may be the mechanism underlying this association.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0021-9150
1879-1484
DOI:10.1016/j.atherosclerosis.2004.07.006